Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (21-30 of 387) with videos related to

Pageof 39
Sort By:
American Journal of Clinical Dermatology|August 11, 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and AbrocitinibSandra Ferreira, Emma Guttman-Yassky, Tiago Torres
Drugs|May 17, 2023
Baricitinib for the Treatment of Alopecia AreataEgídio Freitas, Emma Guttman-Yassky, Tiago Torres
The Journal of Investigative Dermatology|September 14, 2013
Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitisNikhil Dhingra, Nicholas Gulati, Emma Guttman-Yassky
American Journal of Clinical Dermatology|June 22, 2021
Tralokinumab for the Treatment of Atopic DermatitisEgídio Freitas, Emma Guttman-Yassky, Tiago Torres
The Journal of Allergy and Clinical Immunology|October 6, 2014
Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesDonald Y M Leung, Emma Guttman-Yassky
Expert Opinion on Biological Therapy|January 24, 2019
Current and emerging biologic and small molecule therapies for atopic dermatitisRandall Li, Suhail Hadi, Emma Guttman-Yassky
Journal of the American Academy of Dermatology|May 28, 2026
Beyond T helper 2 cells: Integrating immune, barrier, microbial, and neuroimmune pathways in atopic dermatitis pathogenesisJerry Zhou, Jacob Fiedler, Emma Guttman-Yassky
Dermatologic Therapy|December 11, 2021
Good practice intervention for clinical assessment and diagnosis of atopic dermatitis: Findings from the atopic dermatitis quality of care initiativeStephan Weidinger, Audrey Nosbaum, Eric Simpson, et al.
Expert Review of Proteomics|May 25, 2021
Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitisDaniela Mikhaylov, Ester Del Duca, Emma Guttman-Yassky
Therapeutics and Clinical Risk Management|January 7, 2021
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key ChallengesCelina Dubin, Ester Del Duca, Emma Guttman-Yassky
Pageof 39

Showing results (21-30 of 387) with videos related to

Sort By:
Pageof 39
American Journal of Clinical Dermatology|August 11, 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and AbrocitinibSandra Ferreira, Emma Guttman-Yassky, Tiago Torres
Drugs|May 17, 2023
Baricitinib for the Treatment of Alopecia AreataEgídio Freitas, Emma Guttman-Yassky, Tiago Torres
The Journal of Investigative Dermatology|September 14, 2013
Mechanisms of contact sensitization offer insights into the role of barrier defects vs. intrinsic immune abnormalities as drivers of atopic dermatitisNikhil Dhingra, Nicholas Gulati, Emma Guttman-Yassky
American Journal of Clinical Dermatology|June 22, 2021
Tralokinumab for the Treatment of Atopic DermatitisEgídio Freitas, Emma Guttman-Yassky, Tiago Torres
The Journal of Allergy and Clinical Immunology|October 6, 2014
Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesDonald Y M Leung, Emma Guttman-Yassky
Expert Opinion on Biological Therapy|January 24, 2019
Current and emerging biologic and small molecule therapies for atopic dermatitisRandall Li, Suhail Hadi, Emma Guttman-Yassky
Journal of the American Academy of Dermatology|May 28, 2026
Beyond T helper 2 cells: Integrating immune, barrier, microbial, and neuroimmune pathways in atopic dermatitis pathogenesisJerry Zhou, Jacob Fiedler, Emma Guttman-Yassky
Dermatologic Therapy|December 11, 2021
Good practice intervention for clinical assessment and diagnosis of atopic dermatitis: Findings from the atopic dermatitis quality of care initiativeStephan Weidinger, Audrey Nosbaum, Eric Simpson, et al.
Expert Review of Proteomics|May 25, 2021
Proteomic signatures of inflammatory skin diseases: a focus on atopic dermatitisDaniela Mikhaylov, Ester Del Duca, Emma Guttman-Yassky
Therapeutics and Clinical Risk Management|January 7, 2021
Drugs for the Treatment of Chronic Hand Eczema: Successes and Key ChallengesCelina Dubin, Ester Del Duca, Emma Guttman-Yassky
Pageof 39